Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Novavax Raises FY2025 Sales Guidance from $1.000B-$1.050B to $1.040B-$1.060B vs $1.051B Est

Author: Benzinga Newsdesk | November 06, 2025 08:03am

Novavax (NASDAQ:NVAX) raises FY2025 sales outlook from $1.000 billion-$1.050 billion to $1.040 billion-$1.060 billion vs $1.051 billion estimate.

Posted In: NVAX